22/04/2020 : Theradiag committed to fight Covid-19 and reviews the potential impact for 2020

Croissy-Beaubourg, April 22, 2020, 6:00pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER) specializes in in vitro diagnostics and theranostics. Strategic positioning and decisions on Covid-19 serological testsFollowing the approval of Theradiag’s Board of Directors, at a…

Continue Reading22/04/2020 : Theradiag committed to fight Covid-19 and reviews the potential impact for 2020

21/04/2020 : Information on the Annual General Meeting to be held in closed session on Thursday, May 14, 2020

Croissy-Beaubourg, April 21, 2020, 5:45pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specialized in in vitro diagnostics and theranostics, hereby confirms the holding of its Annual General Meeting on May 14, 2020 at…

Continue Reading21/04/2020 : Information on the Annual General Meeting to be held in closed session on Thursday, May 14, 2020